Literature DB >> 12417069

[Hemocoagulase in abdominal operation and its effect on hemoagglutination].

Mingwei Zhu1, Jinduo Cao, Zhengeng Jia, Zhiquan Duan, Guojin Liu, Junmin Wei, Haikong Long.   

Abstract

OBJECTIVE: To evaluate the hemostatic role of hemocoagulase in abdominal operation and its effects on coagulation.
METHODS: 180 patients receiving abdominal operation were studied prospectively by randomized, double-blind controlled and multicenter design. They were divided into Hemocoagulase group (60 patients), lizhixue group (60), and manitol hexanitrate group (60). The groups were, observed in terms of the effects on hemostatic time, hemorrhagic volume, hemorrhagic volume per square unit, and body coagulation (BT, CT, PT, APTT and PLT) parameters.
RESULTS: The groups received different drugs. The average hemostatic time in the hemocoagulase group was 121.6 s, hemorrhagic volume was 9.6 g, and hemorrhagic volume per square unit was 0.2 g. The similar results were observed in the lizhixue group (P > 0.05), but they were significantly different (P < 0.05) from those of the manitol hexanitrate group (159.2 s, 12.49 g, 0.3 g). In the hemocoagulase and lizhixue groups hemorrhagic and hemoagglution time decreased 30 minutes and 1 day after operation. This finding was significantly differenct from that in the manitol hexanitrate group (P < 0.05).
CONCLUSION: Hemocoagulase plays a good hemostatic role in the hemorrhagic capillary at abdominal incision.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12417069

Source DB:  PubMed          Journal:  Zhonghua Wai Ke Za Zhi        ISSN: 0529-5815


  2 in total

1.  Effects of botropase on clotting factors in healthy human volunteers.

Authors:  Ashok K Shenoy; K V Ramesh; Mukta N Chowta; Prabha M Adhikari; U P Rathnakar
Journal:  Perspect Clin Res       Date:  2014-04

2.  Hemocoagulase reduces postoperative bleeding and blood transfusion in cardiac surgical patients: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Yun-Tai Yao; Xin Yuan; Neng-Xin Fang
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.